Detalhe da pesquisa
1.
Josep Baselga (1959-2021).
Cell
; 184(13): 3349-3351, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34171315
2.
Cholesterol is required for transcriptional repression by BASP1.
Proc Natl Acad Sci U S A
; 118(29)2021 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34266955
3.
UDP-glucose pyrophosphorylase 2, a regulator of glycogen synthesis and glycosylation, is critical for pancreatic cancer growth.
Proc Natl Acad Sci U S A
; 118(31)2021 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34330832
4.
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.
Mol Cancer
; 22(1): 138, 2023 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37596643
5.
TRI_tool: a web-tool for prediction of protein-protein interactions in human transcriptional regulation.
Bioinformatics
; 33(2): 289-291, 2017 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27605104
6.
WT1 regulates the development of the posterior taste field.
Development
; 141(11): 2271-8, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24803588
7.
Presenilin influences glycogen synthase kinase-3 ß (GSK-3ß) for kinesin-1 and dynein function during axonal transport.
Hum Mol Genet
; 23(5): 1121-33, 2014 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24105467
8.
Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation.
Hum Mol Genet
; 23(15): 3958-74, 2014 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24619359
9.
Mechanisms of transcriptional regulation by WT1 (Wilms' tumour 1).
Biochem J
; 461(1): 15-32, 2014 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24927120
10.
Epigenetic mechanisms of cancer progression and therapy resistance in estrogen-receptor (ER+) breast cancer.
Biochim Biophys Acta Rev Cancer
; 1879(3): 189097, 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38518961
11.
ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma.
Oncogene
; 43(6): 395-405, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38066089
12.
Methylation of the chromatin modifier KMT2D by SMYD2 contributes to therapeutic response in hormone-dependent breast cancer.
Cell Rep
; 43(5): 114174, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38700982
13.
ERK Hyperactivation Serves as a Unified Mechanism of Escape in Intrinsic and Acquired CDK4/6 Inhibitor Resistance in Acral Lentiginous Melanoma.
Res Sq
; 2023 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37131684
14.
Cell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreatic Cancer.
Cancer Discov
; 13(6): 1428-1453, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36946782
15.
WT1 and its transcriptional cofactor BASP1 redirect the differentiation pathway of an established blood cell line.
Biochem J
; 435(1): 113-25, 2011 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21269271
16.
A Unique FOXA1-Associated Chromatin State Dictates Therapeutic Resistance in Lobular Breast Cancer.
Cancer Res
; 82(20): 3668-3670, 2022 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36245246
17.
Epigenetic Mechanisms Influencing Therapeutic Response in Breast Cancer.
Front Oncol
; 12: 924808, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35774123
18.
The Oncogenic PI3K-Induced Transcriptomic Landscape Reveals Key Functions in Splicing and Gene Expression Regulation.
Cancer Res
; 82(12): 2269-2280, 2022 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35442400
19.
FOXA1 mutations influence the therapeutic response of breast cancer by altering chromatin state.
Mol Cell Oncol
; 8(3): 1891831, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34027035
20.
The present and future of PI3K inhibitors for cancer therapy.
Nat Cancer
; 2(6): 587-597, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35118422